Identify one indicator for a narcotic antagonist to be prescribed?

A) Monoamine oxidase:
Monoamine oxidase (MAO) is an enzyme, not a neurotransmitter. It is responsible for breaking down certain neurotransmitters, such as dopamine, serotonin, and norepinephrine, in the brain and other parts of the body. While it plays a crucial role in regulating neurotransmitter levels, it is not itself a neurotransmitter.

B) Cholinesterase:
Cholinesterase is also an enzyme, not a neurotransmitter. It breaks down acetylcholine (ACh) at synaptic junctions to terminate its action after it has transmitted a nerve impulse. This enzyme is important for the proper functioning of cholinergic synapses but does not function as a neurotransmitter.

C) Acetylcholine (ACh):
Acetylcholine (ACh) is a neurotransmitter. It is released by nerve cells at cholinergic synapses and plays a key role in both the peripheral and central nervous systems. ACh is involved in transmitting nerve impulses to muscles (muscle contraction) and is also important in cognitive functions like memory and learning in the brain.

D) Calcium:
Calcium is a vital ion involved in many cellular processes, including muscle contraction and neurotransmitter release. However, it is not a neurotransmitter. It plays a role in the function of neurotransmitters but does not act as one itself.

A) Parkinson disease is characterized by an imbalance of dopamine and acetylcholine:
The decrease in dopamine results in an imbalance between dopamine and acetylcholine. Normally, dopamine and acetylcholine work in a balanced manner to regulate motor control. As dopamine levels decrease in Parkinson's disease, acetylcholine's effects become more prominent, leading to motor symptoms such as tremors, rigidity, and bradykinesia (slowness of movement).

B) Parkinson disease involves increased dopamine production and decreased acetylcholine:
This statement is incorrect. In Parkinson's disease, there is actually a decrease in dopamine production, not an increase. The disease is characterized by the degeneration of dopamine-producing neurons, leading to the motor symptoms typical of Parkinsonism. The imbalance in Parkinson's disease is primarily one of decreased dopamine and relatively increased acetylcholine activity.

C) Alzheimer disease is caused by decreased amounts of dopamine and degeneration of cholinergic neurons:
While Alzheimer's disease does involve a degeneration of cholinergic neurons (specifically those that release acetylcholine), the primary pathology is related to the accumulation of amyloid plaques and tau tangles, not primarily a decrease in dopamine. Alzheimer's disease is primarily associated with a deficiency in acetylcholine, not dopamine, leading to cognitive impairments, rather than motor deficits.

D) Alzheimer disease involves a possible excess of acetylcholine and neuritic plaques:
This statement is incorrect. Alzheimer's disease is characterized by a deficiency of acetylcholine, which plays a crucial role in memory and cognitive function. The hallmark pathologic features of Alzheimer's disease include the presence of neuritic plaques (formed from amyloid beta) and neurofibrillary tangles (composed of tau protein), not an excess of acetylcholine.